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INTRODUCTION
Breast core needle biopsy (CNB) is an established method
for diagnosing benign and malignant breast disease and
CNB is widely used in daily practice. However, CNB sam-
ples only part of a lesion, and this can be the reason for
an inaccurate diagnosis.(1) This size limitation of CNB
gives rise to important diagnostic problems because one
of the important factors for making the differential diag-
nosis between atypical ductal hyperplasia (ADH) and low-
grade ductal carcinoma in situ (DCIS) is the size of the
lesion.(2,3) Previous studies have reported that ADH in
a CNB showed significant discordance in the subsequent
surgical excision specimens for which 33-87% demon-
strated ductal carcinoma such as DCIS and invasive ductal
carcinoma (IDC).(4-11) Therefore, surgical excision is
presently recommended when ADH is diagnosed in a
CNB. Investigations to determine the factors that are
predictive of more advanced lesions in surgical excision
specimens when ADH was diagnosed in the CNB have
suggested cytologic atypia,(11) more than 4 foci (7) and
micropapillary architecture (7), yet consistent results
were not demonstrated. 
The purpose of this study was to identify the predictive
factors that suggest the diagnosis of ductal carcinoma in
the subsequent surgical excision specimens when ADH
is diagnosed in a CNB.
METHODS
The surgical pathology archives at Severance Hospital
were searched for those breast CNBs that were diagnosed
as ADH and there were subsequent surgical excision spec-
imens between January 2000 and December 2008. This
study was approved by the Institutional Review Board
of Severance University Hospital (4-2009-0285). Fifty
Purpose: Our purpose was to identify the factors in a breast
core needle biopsy (CNB) of atypical ductal hyperplasia
(ADH) that are predictive for carcinoma in the subsequent
excision specimens. Methods: We performed a retrospective
pathologic review of 50 cases that were diagnosed as ADH
via the CNB and that had the corresponding excision spec-
imens. Results: The size of the largest ADH foci in the CNBs
was 0.8±0.6 mm (mean±SD) for benign proliferative dis-
ease (BPD, n=12), 1.0±0.5 mm (mean±SD) for ADH (n=
9) and 1.3±0.8 mm (mean±SD) for malignant lesions (n=
29) in excision specimens (p=0.105). Among the 30 cases
showing stromal alterations around the ducts with ADH in
the CNBs, 9 cases (30.0%) were BPD or ADH and 21 cases
(70.0%) were malignant lesions in the excision specimens
(p=0.004). Conclusion: As the stromal alterations around
the ADH were noted in the CNB, there was an increased
likelihood that more advanced lesions would be identified in
the surgical excision specimens.
Key Words: Breast hyperplasia, Needle biopsy, Risk factor
Journal of
Breast 
Cancer
ORIGINAL ARTICLE
Factors in the Breast Core Needle Biopsies of Atypical Ductal
Hyperplasia that Can Predict Carcinoma in the Subsequent Surgical
Excision Specimens
Ja Seung Koo, Min Jung Kim1, Eun-kyung Kim1, Woohee Jung
Departments of Pathology and 1Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea
Correspondence: Woohee Jung 
Department of Pathology, Gangnam Severance Hospital, Yonsei
University College of Medicine, 612 Eonjuro, Gangnam-gu, Seoul
135-720, Korea
Tel: 02-2019-3541, Fax: 02-3463-2103
E-mail: Jungwh96@yuhs.ac
Received:October 8, 2009   Accepted:December 21, 2009
132
J Breast Cancer 2010 June; 13(2): 132-7 DOI: 10.4048/jbc.2010.13.2.132
Atypical Ductal Hyperplasia 133
cases with a main diagnosis of ADH alone were included.
Sonographically guided core needle biopsies were per-
formed, using the freehand technique, with a high-res-
olution sonographic unit and a 7.5- or 12-MHz linear
array transducer (HDI 5000 or 3000, Philips ATL, Logic
9, GE Healthcare, Bothell, USA). All the biopsies were
done as outpatient procedures under local anesthesia
with the patient in the supine position. An automated
gun (Pro-Mag 2.2; Manan Medical Products, Northbrook,
USA) and a 14-gauge Tru-Cut needle with a 22-mm
throw (SACN Biopsy Needle; Medical Device Technologies,
Gainesville, USA) were used. The biopsies were performed
by radiologists who specialized in interpreting breast
images and performing percutaneous breast biopsies under
sonographic guidance. Four or 5 core samples per lesion
were obtained, according to our standard protocol. The
breast CNBs were submitted for microscopic examination.
Microscopic examination of the CNB and the surgical
excision tissue was performed retrospectively by a pathol-
ogist who specialized in breast pathology (JSK). The diag-
nostic criteria for ADH were those of Page and Rogers (3)
with the size criteria of Tavassoli and Norris.(12) All the
breast CNB slides were reviewed and the following data
was recorded: the largest lesion size, the number of large
ducts and/or terminal duct-lobular units affected, the
architecture, stromal alterations and inflammation, and
the number of biopsy cores. When the‘ADH’-like changes
were present in multiple cores, we measured the largest
lesion size in any individual core. In addition, we measured
the largest diameter of the ADH area by using the micro-
scopic ruler contained in the microscope. The stromal
alterations included fibroblast proliferation, fibrosis and
sclerosis. When stromal alterations were evaluated, we
compared the periductal stroma around the ADH to the
periductal stroma around the coexisting normal ductal/
lobular structures. A retrospective evaluation of slides
from the subsequent surgical excision specimens was
performed without the pathologist having any knowledge
of the CNB findings. The surgical excision specimens
were evaluated for the presence of DCIS, IDC and ADH.
For the specimens showing carcinoma in the subsequent
surgical excisions, the nuclear and/or histologic grade
was recorded using the Van Nuys grading system (13) for
DCIS and the Elston modification of the Scarff-Bloom-
Richardson criteria (14) was used for IDC. The data was
statistically processed using SPSS for Windows version
12.0 (SPSS Inc., Chicago, USA). For determining the sta-
tistical significance, Student’s t test and Fisher’s exact
test were used for the continuous and categorical vari-
ables, respectively. Correlation analysis was performed
by using Pearson’s correlation test. Statistical significance
was assumed for p values <0.05.
RESULTS
Pathologic features of ADH in the CNBs
Table 1 shows the pathologic features of ADH in the
CNBs. The size of the largest ADH focus was 1.1±0.7 mm
(mean±SD). Among the 50 cases, the number of iden-
tifiable ADH foci was ≤2 in 23 cases (46.0%), 3-5 in 20
(40.0%) and ≥6 in 7 (14.0%). The architecture of the ADH
was cribriform in 42 cases (84.0%), combined cribriform
and micropapillary in 3 (6.0%), combined cribriform and
papillary in 3 (6.0%), combined cribriform and solid in 1
(2.0%) and solid in 1 (2.0%). Stromal alterations such as
Table 1. Pathologic features of ADH in CNB
No. of cases (%)
(n=50) 
Pathologic feature
Size of largest foci (mean±SD, mm) 1.1±0.7
No. of ADH foci 
≤2 23 (46.0)
3-5 20 (40.0)
≥6 7 (14.0)
Architecture
Cribriform 42 (84.0)
Cribriform+micropapillary 3 (6.0)
Cribriform+papillary 3 (6.0)
Cribriform+solid 1 (2.0)
Solid 1 (2.0)
Stromal alteration 30 (60.0)
Stromal inflammation 7 (14.0)
No. of core biopsies
3 13 (26.0)
4 27 (54.0)
5 8 (16.0)
6 2 (4.0)
ADH=atypical ductal hyperplasia; CNB=core needle biopsy.
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fibrosis and fibroblast proliferation around the ductal
structures showing ADH were noted in 30 (60.0%) cases
(Figure 1) and the periductal stromal inflammation ob-
served in 7 cases (14.0%) was predominantly composed
of lymphocytes. 
Pathologic features of the subsequent surgical
excision specimens
Table 2 demonstrates the final pathologic diagnosis of
the subsequent surgical excision specimens. IDCs of 0.7
and 0.3 cm in size were identified in 2 cases (4.0%). In
addition, DCIS components 1.2 and 2.0 cm in size were
identified around the IDCs in these 2 cases. The nuclear
and histologic grades of the IDCs in both cases were 1.
DCIS was observed in 27 cases (54.0%). The architecture
of the DCIS was cribriform in 16 cases (59.3%), combined
cribriform and papillary in 8 (29.6%), combined cribriform
and solid in 2 (7.4%) and papillary in 1 (3.7%). The Van
Nuys grade was 1 (a non-high nuclear grade without
comedonecrosis) in 16 cases (59.3%) and 2 (a non-high
nuclear grade without comedonecrosis) in 11 cases (40.7%).
Figure 1. Histopathologic features in core needle biopsy (CNB) and subsequent surgical excision. Foci of atypical ductal hyperplasia
(ADH) were identified in CNB, and there were no stromal alterations around ducts showing ADH (A, H&E stain, ×400). In subsequent
surgical excision specimens, there were 2 foci of ADH (B, H&E stain, ×200). In NCB, ADH foci were noted, and there was periductal
fibroblast proliferation and fibrosis in periductal stroma (C, H&E stain, ×400). In subsequent surgical excision specimens, there was
ductal carcinoma in situ showing periductal fibroblast proliferation, fibrosis, and inflammatory cell infiltration (D, H&E stain, ×200).
C D
A B
Table 2. Final pathologic diagnosis of surgical excision spec-
imens
No. of cases (%)
(n=50) 
Final pathologic diagnosis
IDC with intraductal component 2 (4.0)
DCIS 27 (54.0)
ADH 9 (18.0)
BPD without atypia 12 (24.0)
IDC=invasive ductal carcinoma; DCIS=ductal carcinoma in situ; ADH=
atypical ductal hyperplasia; BPD=benign proliferative disease.
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The size of the DCIS was 1.3±0.6 cm (mean±SD; range,
0.3-3.0 cm). ADH was diagnosed in 9 cases (18.0%). The
architecture was cribriform in all the ADH cases and the
size of the ADH was 0.6±0.2 cm (mean±SD; range, 0.2-
1.0 cm). Benign proliferative disease (BPD) without atypia
was identified in 12 cases (24.0%); intraductal papilloma
was identified in 5 (41.6%), fibrocystic disease was iden-
tified in 2 (16.6%), adenosis was identified in 1 (8.3%), com-
plex sclerosing lesion was identified in 1 (8.3%), mucocele-
like lesion was identified in 1 (8.3%), usual ductal hyper-
plasia was identified in 1 (8.3%) and lactational hyper-
plasia was identified in 1 (8.3%). Periductal fibrosis and
sclerosis were noted in all 5 cases of intraductal papilloma.
Predictive pathologic factors in the CNBs for 
making the pathologic diagnosis of the surgical
excision specimens
Table 3 shows the correlation analysis between patho-
logic parameters in the CNBs and the pathologic diag-
nosis of the surgical excision specimens. The size of the
largest ADH foci in the CNBs was 0.8±0.6 mm (mean±
SD) for the final diagnosis of BPD, it was 1.0±0.5 mm
(mean±SD) for the final diagnosis of ADH and it was
1.3±0.8 mm (mean±SD) for the final diagnosis of IDC or
DCIS, without statistical significance (p=0.105). Stromal
alterations around the ductal structures showing ADH in
the CNB were noted in 8 cases (16.0%) of BPD, in 1 case
(2.0%) of ADH and in 21 (42.0%) of IDC or DCIS with sta-
tistical significance (p=0.004). The number of ADH foci
in the CNB, stromal inflammation, ADH architecture and
the number of CNB cores showed no statistical signif-
icance between BPD, ADH and IDC/DCIS (p=0.315, 0.409,
0.685, and 0.585, respectively). 
DISCUSSION
In this study, among the 50 patients who were diag-
nosed with ADH in their CNBs, 29 (58.0%) cases showed
more advanced lesions such as DCIS and IDC in the sur-
gical excision specimens. This figure is compatible with
that of previous studies in which the underestimation
rate of ADH in a CNB was 33-87%.(4-11) The wide range
of underestimation was due to the differences in the ADH,
the patient selection criteria and the number of biopsy
cores. The major limitation of CNB is that it only inves-
tigates a restricted area of the entire lesion. Therefore,
the diagnostic accuracy of CNB increases as the numbers
of CNBs increases. Previous studies have reported that
more than 10 samples per lesion substantially reduced
the underestimation rate of ADH.(8) However, it seems
almost impossible to obtain more than 10 NCB samples
from each patient. Therefore, it is important to determine
the predictive factors of more advanced lesions in the
surgical excision specimens when ADH is diagnosed in
the CNB. 
This study showed that stromal alterations such as
fibrosis around the ducts showing ADH occurred in the
CNB, the likelihood that ductal carcinoma would be identi-
fied in the surgical excision specimens increased. Although
a previous study reported that more than 4 foci of ADH
Table 3. Correlation between pathologic parameters in CNB
and pathologic diagnosis of surgical excision specimens
Final pathologic diagnosis of
surgical excision specimens (%), 
(n=50) 
BPD
(n=12)
p-
value IDC or
DCIS
(n=29)
ADH
(n=9)
Pathologic parameters 
in CNB
Size of largest foci 0.8±0.6 1.0±0.5 1.3±0.8 0.105
(mean±SD, mm)
No. of ADH foci 0.315
≤3 10 (83.3) 6 (66.7) 17 (58.6)
≥4 2 (16.7) 3 (33.3) 12 (41.4)
Stromal alterations 8 (66.7) 1 (11.1) 21 (72.4) 0.004
Stromal inflammation 2 (16.7) 0 5 (17.2) 0.409
Architecture 0.685
Cribriform 9 (75.0) 9 24 (82.7)
Cribriform+micropapillary 1 (8.3) 2 (6.9)
Cribriform+papillary 1 (8.3) 2 (6.9)
Cribriform+solid 1 (3.4)
Solid 1 (8.3) 0
No. of CNB core 0.585
3 2 (16.7) 1 (11.1) 10
4 8 (66.7) 6 (66.7) 13
5 1 (8.3) 2 (22.2) 5
6 1 (8.3) 1
CNB=core needle biopsy; BPD=benign proliferative disease; ADH=
atypical ductal hyperplasia; IDC=invasive ductal carcinoma; DCIS=
ductal carcinoma in situ; SD=standard deviation.
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and a pure micropapillary architecture were predictive
factors,(7) they did not hold true this present study. In
this study, there was no significance difference in the final
diagnosis in excision when subgroup was made according
to the number of ADH foci observed in the CNB (≤3 or
≥4, p=0.315). Therefore, the number of ADH foci in the
CNB was not a predictive factor in this study, and this
was thought to result from the fact that the DCIS com-
ponent was not sufficiently sampled through the CNBs in
many cases. The pattern of ADH in the CNBs was mostly
cribriform (84.0%), and a pure micropapillary pattern was
not identified. Other reports in the literature have sug-
gested that cytologic atypia was associated with individual
cell necrosis in ADH as a predictive factor,(11) but this
finding was not observed in this present study. The cells
forming ADH should be similar to the cells of low-grade
DCIS which showed small, uniform features with rounded
nuclei to define ADH.(3) Therefore, most of the cases of
ADH showing cytologic atypia and individual cell necrosis
were thought to actually come under the diagnosis of
DCIS. When an intraductal proliferative lesion showing
cytologic atypia and individual cell necrosis is identified
in CNB, we believe that the term ‘ atypical intraductal
epithelial hyperplasia’or ‘ intraductal atypia of uncertain
significance’is more appropriate than the diagnosis of
ADH. 
This study demonstrated that the size of the largest
ADH foci in CNB was not a risk factor to detect more
advanced lesions in surgical excision specimens occurred
(p=0.105). Previous studies have reported that the factors
that affect the likelihood of observing DCIS in an exci-
sional biopsy were the initial mammographic size of the
lesion and the amount of the residual lesion after CNB,
suggesting that the size of the lesion was an important
parameter.(15) However, to the best of our knowledge,
there has been no report that has investigated the effect
of the size of the largest ADH foci in a CNB for making
the diagnosis of the surgical excision specimens. It could
be assumed that if the size of the largest ADH foci in-
creased in the CNB, then the size of the entire lesion is
also increased and the possibility of detecting DCIS is
increased. However, there was no significant correlation
between the size of the largest ADH foci in the CNB and
the size of DCIS in the surgical excision specimens (p=
0.097). 
There was a higher probability of detecting ductal car-
cinoma in the surgical excision specimens when observing
stromal alterations such as fibrosis and sclerosis around
the ducts showing ADH (p=0.035). In general, periductal
fibrosis, elastosis and inflammation can be identified in
DCIS, and these features are well associated with high-
grade DCIS.(16) When stromal alterations such as fibrosis
and sclerosis around the ducts showing ADH were iden-
tified in the CNB, the corresponding surgical excision
tissue also showed periductal stromal changes around the
DCIS (Figure 1). In addition, 2 cases of IDC with extensive
DCIS showed stromal reactions around both the invasive
components and the surrounding DCIS. Therefore, the
ADH identified in the CNB where periductal stromal alter-
ation occurred was thought to fall under DCIS, but ADH
was diagnosed according to the quantitative criteria.
Stromagenesis in breast cancer can be classified into 3
stages:‘ normal stroma,’indicating a neoplastic pro-
gression-restraining environment; ‘ primed stroma,’
indicating a permissive, supportive landscape for tumor
progression, and‘ activated stroma,’indicating an ad-
vanced neoplastic microenvironment.(17) It is known that
the linear progression from atypical epithelial hyperplasia
to intraductal carcinoma and then to invasive carcinoma
does not always apply to breast carcinogenesis.(18) In fact,
the low- and high-grade DCISs were considered to be
genetically distinct disorders because low-grade DCIS has
shown chromosomal loss at 16q and 17p and high-grade
DCIS has demonstrated chromosomal loss at 11q, 14q,
8p and 13q and chromosomal gain at 17q, 8q and 5p.(18,
19) Therefore, the tumor stroma to be induced should
interact with epithelial neoplastic cells that contain dis-
tinct genetic alterations.(20) This postulation could ex-
plain the finding of stromal alterations around the duct
lesions in both the CNBs and the surgical excision spec-
imens. Nine cases that showed stromal alterations around
ADH in the CNB did not demonstrate ductal carcinoma
in the surgical excision specimens. Out of these 9 cases,
5 were intraductal papilloma associated with sclerosis
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(sclerosing papilloma) and 1 was a complex sclerosing
lesion. Therefore, a total of 6 cases were BPD, which could
be associated with stromal change such as fibrosis and
sclerosis. Further studies should be conducted to distin-
guish the stromal alterations in benign and malignant
breast disease. 
CONCLUSION
As the stromal alterations around ADH occurred in the
CNB, there was an increased likelihood that more ad-
vanced lesions would be identified in the surgical excision
specimens. Therefore, the stromal alterations included
fibroblast proliferation, fibrosis, and sclerosis should be
described in pathology report when the diagnosis of ADH
is made in CNB.
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